The present study investigated changes in cardiac energy metabolism and function in patients with dilated cardiomyopathy (DCM) before and after exercise training (ET) with phosphorus-31 magnetic resonance spectroscopy (MRS) in combination with magnetic resonance imaging (MRI).
Background
Exercise training might have a beneficial role on myocardial function and oxidative metabolism in DCM, but it is unclear whether the additional load on the failing heart leads to deterioration of cardiac energy metabolism.
Methods
Twenty-four patients were randomized to an exercise (age 53 Ϯ 12 years) or a control (age 56 Ϯ 6 years) group. Supervised ET was performed for 2 months, followed by 6 months of self-regulated training. At baseline and 2 and 8 months, maximal exercise testing along with quantitative MRS and MRI studies were performed.
Results
The effectiveness of ET was demonstrated by a 17% increase in peak oxygen uptake (p Ͻ 0.05). Exercise training improved left ventricular (LV) end-systolic volume (p Ͻ 0.05) and LV ejection fraction (30 Ϯ 15% vs. 37 Ϯ 15%; p Ͻ 0.01) but not right ventricular parameters. The improvement in cardiac function was not accompanied by changes in cardiac high-energy phosphate concentrations; phosphocreatine, adenosine triphosphate, and the phosphocreatine/adenosine triphosphate ratio were all unchanged after training.
Conclusions
The observation that LV function improved and LV energy metabolism remained unchanged suggests that the beneficial effect of ET on LV function is achieved without adversely affecting metabolism. Derangement of cardiac energetics is one of the hallmarks of the failing myocardium (1) and has been implicated as a major contributor to the pathophysiology of contractile dysfunction (2) . Myocardial high energy phosphate metabolism is a sensitive indicator of energetic derangement and can be measured noninvasively by phosphorus-31 ( 31 P) magnetic resonance spectroscopy (MRS) (3, 4) . We and others have shown that, in the failing human heart, levels of phosphocreatine (PCr), adenosine triphosphate (ATP), and their ratio (PCr/ATP ratio) are all reduced (5, 6) , and these indexes are correlated with left ventricular (LV) dysfunction and clinical status (6) . In patients with dilated cardiomyopathy (DCM), the PCr/ATP ratio has also been shown to be a strong predictor of prognosis (7) .
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The past 15 years of clinical trials in heart failure have shown that energy-sparing treatments, such as angiotensinconverting enzyme (ACE) inhibitors or beta-blockers (8 -11) , improve prognosis in heart failure, whereas energycostly treatment with catecholamines (12) or phosphodiesterase (PDE) inhibitors (13) increases mortality. Inter-estingly, it is conceivable that therapeutic exercise training (ET) might be an exception to this rule, at least in patients with nonischemic heart failure, where this form of treatment has met substantial recent enthusiasm (14) . Besides favorable effects on peripheral adaptations (15) , ET seems to have direct effects on the heart, including improved myocardial perfusion, volumes, and function (16, 17) . Additionally, ET has recently been associated with lower mortality and hospital readmission in heart failure (18 -20) . Recent positron emission tomography (PET) studies have demonstrated marked alterations in myocardial oxygen metabolism in heart failure (21) , and ET seems to have a favorable influence on myocardial oxidative metabolism (22) . Therefore, in the present controlled study, we tested the hypothesis that chronic ET in patients with moderate DCM improves cardiac function and might benefit cardiac energy metabolism. To achieve this, we sequentially studied sedentary patients and those subjected to ET with a moderate reduction of LV ejection fraction (EF) in echocardiography (mean 27 Ϯ 10), with magnetic resonance imaging (MRI) to measure cardiac volumes and 31 P-MRS to quantify absolute and relative levels of cardiac high-energy phosphates.
Methods
Patient characteristics. Twenty-four patients with nonischemic DCM were randomized to an exercise or a control group (12 each). Inclusion criteria were a reduction in LVEF below 40% and absence of coronary artery disease as confirmed by invasive coronary angiography. Table 1 summarizes baseline data. Both groups had similar clinical and demographic data, including age, height, weight, pulmonary function, medication status, and peak oxygen uptake (VO 2 ). All subjects were receiving maximal therapeutic medical therapy as determined by their personal physician.
Subjects were evaluated before and after a 2-month training period and also after an 8-month follow-up. A 72-year-old male patient from the exercise group died after 4 months-who refused training after the baseline examination-and a 72-year-old female patient from the control group died after the baseline examination. Two additional patients in the control group refused to be tested at the 8-month evaluation. Therefore, 11 patients in each group had at least 1 repeated imaging analysis, and the presented data are based on these patient groups. Patients in the exercise group underwent 5 supervised training sessions/ week lasting 45 min, whereas patients in the control group received standard care. No change of drug types and/or dosages occurred in either group during the 8 months of follow-up.
Written informed consent was obtained from all patients, and the study was approved by the local ethics committee. All patients had stable symptoms before randomization. All were limited by fatigue, dyspnea, or both on baseline exercise testing, and none had clinical evidence of pulmonary disease. None of the patients had a pacemaker; a history of metal fragments, implants, or vascular clips; significant arrhythmias; unstable angina pectoris; or claustrophobia. Exercise testing. All patients were requested to abstain from food, coffee, and tobacco products for at least 3 h before exercise. Standard pulmonary function tests were performed. With an individualized ramp protocol, maximal exercise testing was performed with an electrically braked cycle ergometer (16) . The patient's subjective level of exertion was quantified each minute with the Borg 6 -20 scale (16) , and all tests were continued to volitional fatigue/ dyspnea. With the Schiller CS-200 metabolic system (Baar, Switzerland), respiratory gas exchange variables were acquired continuously throughout exercise. Gas exchange variables analyzed included VO 2 , carbon dioxide production, minute ventilation, respiratory rate, tidal volume, oxygen pulse, and respiratory exchange ratio. The lactate threshold was determined by 2 experienced observers (J.M. and P.D.) blinded to the study group. ET. Subjects in the exercise group participated in training sessions as outpatients for 2 months. Five sessions/week for a duration of 45 min were performed. Warm-up and cool-down periods preceded and followed each exercise Beta-blockers 9 9
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session. Cycle ergometry training was emphasized, but a variety of dynamic exercises were included. Exercise intensity was targeted to maintain a level commensurate with 60% to 80% of maximal VO 2 and a continuous perceived exertion rating between 13 and 15 (Borg 6 to 20 scale). Exercise intensity was progressed throughout the study period on an individualized basis as tolerated. All exercise sessions were supervised directly by a medical resident, an exercise physiologist, or both. Between the 2-and 8-month evaluation periods, subjects in the exercise group were counseled and encouraged to remain physically active; we recently demonstrated that these individuals maintain activity levels consistent with the maintenance of fitness up to 2 years (23). MRI. The MRS and MRI were performed with a 1.5-T scanner (Magnetom VISION, Siemens, Erlangen, Germany). For imaging, subjects were studied in the supine position with a phased-array body coil. Short-and long-axis cine MRI were performed with a 2-dimensional gradient echo sequence and a slice thickness of 8 mm as described previously (24) . Right ventricular (RV) function as well as LV function and mass were analyzed with the ARGUS software version VB31B (Siemens) (24). 31 P-MRS. Patients were examined in the prone position on a commercially available double resonant 31 P/ 1 H-surface coil as previously described (5,25). An external reference was placed below the coil for absolute quantification (25) . Initially, 2-dimensional gradient echo short-axis images were acquired for anatomical information. After an automatic phase-sensitive map-shim, a 31 P-3-dimensionalchemical shift imaging sequence was started (doubleoblique orientation, field of view 400 ϫ 400 ϫ 320 mm 3 , 16 ϫ 16 ϫ 8 phase encoding steps). To increase the signal to noise ratio, nuclear Overhauser enhancement was employed. Total examination time ranged from 45 to 60 min, depending on heart rate. A SUN Sparc Station 20 (SUN Microsystems, Grasbrunn, Germany) was used for postprocessing as previously described (25) . The short-axis images were manually segmented. The Spatial Localization with Optimum Pointspread Function (SLOOP)-program was run to reconstruct local spectra, taking into account the B 1 -field strength, the flip angle, and standard T 1 -values; the resonance amplitudes in the local spectra were fitted with "AMARES" (a method for accurate and reproducible spectroscopic fitting) (26) . The applied prior knowledge allowed independent fitting for PCr and ATP with an allowed linewidth in an interval between 2 and 20 Hz and took j-coupling for ATP of 16 Hz into account. Correction for the effect of saturation was considered with the mean time of repetition of each experiment, the actual flip angle and published T 1 -values. Differences in coil loading were taken into account by calculation of the presumed B 1 -field according to Biot-Savart laws. Nuclear Overhauser enhancement effects were corrected, as previously described (5); briefly, the values for PCr and gamma ATP were 1.6 and 1.4. A spatially dependent consideration of nuclear Overhauser enhancement was not used. The amplitude of the resonance of gamma ATP was taken as the value for ATP. Owing to the optimal adaptation of voxel shape to anatomical regions, no blood correction was necessary. Estimation of myocardial efficiency. The LV work power and myocardial efficiency in patients with DCM have previously been determined with echocardiography and PET analysis of oxidative metabolism ([ 11 C] acetate) (22, 27) . To determine myocardial efficiency, the functional parameter (LV work power/gram ϭ heart rate ϫ blood pressure ϫ stroke volume/LV mass) was divided by the metabolic parameter (LV k mono ). In contrast to LV k mono , which has a dimension beneath 0, the metabolic parameter analyzed in the present study (PCr concentration) has a dimension above 0. To allow comparison of the present data with previous PET data, the functional parameter "LV work power/gram" data was multiplied with the metabolic parameter (PCr concentration). Statistics. NCSS statistical software (Kayesville, Utah) was used to perform multivariate analysis of variance procedures between patients randomized to the exercise and control groups. Group (exercise or control) and test (baseline vs. follow-up) were respected as factors, and the exercise test variable (e.g., peak VO 2 , heart rate) as the response variable. This was followed by a Bonferroni post hoc procedure for within-group comparisons. Data are presented as mean Ϯ SD. Evaluation of MRI and MRS datasets was performed blinded.
Results

Exercise testing responses.
Exercise testing responses before and after the study period are presented in Table 2 . Both groups achieved mean maximal respiratory exchange ratios Ͼ1.1 and mean perceived exertion levels Ͼ19.0, suggesting that maximal efforts were generally achieved. No differences were observed within or between groups in maximal heart rate or blood pressure. The exercise group demonstrated a 17% increase in peak VO 2 (21.7 Ϯ 3.8 ml/kg/min vs. 25.3 Ϯ 5.2 ml/kg/min, p Ͻ 0.05), a 14% increase in exercise time (p Ͻ 0.05), and a 22% increase in peak watts achieved. No differences were observed among control subjects in these measures of exercise tolerance.
At the lactate threshold, marked improvements in exercise responses were documented in the exercise group. A 46% increase in VO 2 (13.2 Ϯ 4.0 ml/kg/min vs. 19.3 Ϯ 5.3 ml/kg/min, p Ͻ 0.01), a 78% increase in exercise time (4.2 Ϯ 2.1 min to 7.5 Ϯ 2.5 min, p Ͻ 0.01), and an 81% increase in peak watts achieved (58 Ϯ 32 W to 105 Ϯ 44 W, p Ͻ 0.01) were observed at this point. Concomitant increases in heart rate (p Ͻ 0.05), minute ventilation (p Ͻ 0.01), VCO 2 (p Ͻ 0.01), and respiratory exchange ratio (p Ͻ 0.01) were observed. MRI. The LV mass, LV and RV end-diastolic volume, end-systolic volume, stroke volume, and EF are presented in Table 3 . Overall, changes in measures of LV size and function were not significantly different between groups at 2
months. However, a reduction in end-systolic volume (163 Ϯ 78 ml to 136 Ϯ 69 ml; p Ͻ 0.05) and an improvement in EF (30 Ϯ 15% to 37 Ϯ 15%; p Ͻ 0.005) were observed in the exercise group after 8 months compared with baseline. In contrast, these parameters were unchanged in the control group. No significant differences in RV size or function Exercise and Gas Exchange Data were observed within or between either group during the training period or after the 8-month follow-up. 31 P-MRS. Table 4 summarizes absolute and relative concentrations of LV high-energy phosphates at baseline and during follow-up. Importantly, no significant changes were observed in myocardial energetics for either the exercise or control groups, as depicted in Figure 1 , which presents paired data for individual patients. For the control group, most patients showed similar PCr concentrations during follow-up, as shown in the example in Figure 2 . For the exercise group, a tendency toward improved PCr concentration (PCr baseline 6.0 Ϯ 1.8, PCr 8-month follow-up 6.5 Ϯ 2.5; all units in mmol/kg wet heart weight) could be observed, as shown in the example in Figure 3 . Estimation of myocardial efficiency. Table 5 summarizes changes between baseline and 8-month follow-up in measures of LV work power and efficiency. A trend for higher forward work efficiency was observed for the trained group; however, this change was not statistically significant.
MRI Measures of Ventricular Function
Discussion
The major findings from the present study were: 1) 8 months of ET improved exercise capacity and LV systolic function in patients with DCM; and 2) these improvements were neutral with regard to effects on cardiac energy metabolism, because no adverse short-term (2-month) or long-term (8-month) effects on myocardial energetics were observed. These findings provide further support for the benefits of ET in patients with impaired LV function due to DCM. ET in chronic heart failure. Studies performed in recent years have provided strong evidence for the benefits of ET in chronic heart failure. Although these benefits are largely thought to occur in the periphery (e.g., skeletal muscle and vasculature adaptations), favorable myocardial adaptations have also been reported (28) . The latter studies have included reduced adrenergic and increased vagal tone and improvements in myocardial perfusion (20, 29) and myocardial oxidative metabolism (22) . Nevertheless, ET remains underused, in part because data on survival are limited (20) . A recent collaborative meta-analysis of 801 patients randomized to ET demonstrated a reduction in mortality in patients with heart failure due to LV systolic dysfunction (19) . However, the mechanisms for the potential benefits of training on survival are not fully understood.
Training responses. We observed a 17% increase in peak VO 2 and a considerable 46% increase in VO 2 at the lactate threshold in patients randomized to the exercise group. These training effects are consistent with previous reports (30) . A unique feature of the current study was the evaluation of myocardial adaptations to both short-and long-term training. Initially, a 2-month supervised training regimen was used, followed by an additional 6-month period with self-regulation. Although we do not have exercise test responses at the 8-month evaluation, we Data presented as mean Ϯ SD; concentrations in mmol/kg wet heart tissue weight. No significant differences between groups, either at baseline or at follow-up. Additionally, there were no significant changes during follow-up (p Ͼ 0.05). ATP ϭ adenosine triphosphate; PCr ϭ phosphocreatine; 31 P-MRS ϭ phosphorus-31 magnetic resonance spectroscopy.
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recently observed that self-regulation leads to improvements in exercise capacity that are similar to those among monitored patients (31) and that patients maintained physical activity patterns and fitness levels at least 2 years after participation in a 2-month rehabilitation program (23) . Thus, the myocardial adaptations observed at 8 months are likely attributable at least in part to sustained activity levels (23, 31) . (20) and to improve LV functional parameters in patients with heart failure (30, 32) . The present findings support the concept that these favorable adaptations in LV function might occur with longer-term physical activity. Changes in myocardial perfusion might play an important role in these adaptations (33); however, the molecular mechanisms underlying this effect remain to be investigated.
Little is known about the effects of training on the RV, although it has been shown that RV afterload might be an important determinant of exercise capacity (34) and RVEF is an important predictor of survival in patients with advanced heart failure (35) . Moreover, data concerning effects of ET on the RV, although limited to short-term training and the EF, have reported no significant changes (35) . Including long-term training and a detailed analysis of RV morphology and function, the present study similarly did not demonstrate any changes in RV volumes or function. Cardiac energy metabolism. Reductions of high-energy phosphate content, which can be studied noninvasively with 31 P-MRS, are a key feature of DCM (6). The degree of metabolic alterations assessed by the ratio of the highenergy molecules PCr to ATP has prognostic value for both overall and cardiovascular mortality (7). However, end-stage heart failure might lead to the combined reduction of PCr and ATP (36) , warranting separate quantitative analyses of PCr and ATP content (37) . For the present study the quantitative MRS SLOOP technique was applied, which has the advantage of precise anatomic localization combined with increased sensitivity and reliability (25) . Anatomic voxel alignment by SLOOP yields both PCr and ATP content with minimal contamination (5) . In the present study, the high-energy metabolite levels as well as their ratio fit well with previously published data in comparably diseased patients with DCM and cardiac manifestations of muscular dystrophy (6,38) (mean EF in the present study 31%; most were in Weber class A and B, and none were Weber class D). Effects of ET on energy use in cardiac muscle. Whether the additional load caused by ET on the failing heart would lead to deterioration of cardiac energy metabolism has not been fully explored. It is known for example that positive inotropic therapy increases mortality in heart failure (12, 13) and acute increases in cardiac work decrease phosphocreatine levels in both human and animal studies (39, 40 ). The present study shows that the effect of chronic ET (i.e., increased energy demand and use in 5 45-min periods in our setting) is not detrimental on cardiac energetics and was even beneficial in individual patients This is in accordance with recent PET findings of Stolen et al. (22) , who demonstrated an improvement in oxidative metabolism following ET. Thus, DCM patients are able to withstand the additional cardiac work necessitated by ET without depleting their cardiac high-energy phosphate levels. This observation, together with the beneficial effects on cardiac function, suggests that ET has the potential to improve prognosis in DCM, although this question needs to be studied in a large prospective randomized trial. Study limitations. Contrast-enhanced MRI studies were not performed. Thus, an analysis of first pass perfusion defects for correlation to previous PET perfusion results (21, 22) as well as analysis of late enhancement for detection of myocardial fibrosis was not possible (41) . The sample size of the study is small; however, previous studies showed that a sample size such as 24 patients is an adequate number to document a training effect (23, 31) . Nevertheless, sample size might explain why no significant changes in RV function were observed, because detection of changes in RV function require larger sample sizes than the LV (42) and, additionally, small sample size might also be the reason for the nonsignificant change in LV work power and efficiency.
The ET was not supervised in the interval between early (2-month) and late follow-up (8-month). Therefore, the energy expenditure during this period is not documented precisely. Nevertheless, the exercise group was encouraged to remain physically active, and the surrogate measure for this (peak VO 2 ) suggests that they maintained their fitness. Moreover, previous reports have shown a comparable effect of ET with self-regulation and supervised training at our facility (23, 31) .
This mechanistic proof-of-principle study was not adequately powered to address whether ET has an effect on Myocardial Work and Efficiency at 8 Months P-MRS only allowed the analysis of PCr and ATP content. No changes were found concerning this aspect of energy metabolism. However, the rise of peak VO 2 indicates increased ATP synthesis and use and therefore altered flux through the purine pool (43) .
Conclusions
Exercise training among patients with DCM results in significant improvements in exercise capacity, which are similar to those observed in recent studies among patients with ischemic cardiomyopathy. Training had no short-or long-term adverse effects on myocardial size, function, or energetics. Rather, training resulted in a modest but significant improvement in LV systolic function. These findings provide further support for ET as a treatment modality in patients with impaired LV function due to DCM.
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